ALDH2 Gene rs671 Polymorphism May Decrease the Risk of Essential Hypertension
-
- Mei Xiao-Fei
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Hu Sheng-Da
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Liu Peng-Fei
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Li Fei
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Zhou Xian-Yong
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Zhou Ya-Feng
- Department of Cardiology, The First Affiliated Hospital of Soochow University
-
- Chen Tan
- Department of Cardiology, The First Affiliated Hospital of Soochow University
この論文をさがす
抄録
<p>Aldehyde dehydrogenase-2 (ALDH2) rs671 G>A polymorphism can influence the activity of ALDH2 and may be associated with the risk of essential hypertension (EH). Although many previous studies have explored such a relationship, the conclusion is still controversial.</p><p>The PubMed, Embase, and China National Knowledge Infrastructure databases were searched on the ALDH2 gene and EH. We used the Newcastle-Ottawa Scale to evaluate the quality of the study. Then we calculated the strength of relationship between ALDH2 rs671 mutation and EH by utilizing odds ratios and 95% confidence intervals. Besides, subgroup analysis and sensitivity analysis were performed and the publication bias was assessed.</p><p>There were 12 studies containing 8153 cases and 10,162 controls. Our meta-analysis showed significant association between ALDH2 rs671 polymorphism and EH in four genetic models (the allele model, the homozygote model, the heterozygote model, and the dominant model), whereas it did not indicate this connection in the recessive model. However, a trend of decreased risk still could be seen. Furthermore, we also found an obvious association between rs671 mutation and the risk of EH in the male group than in the female group in all five genetic models.</p><p>We concluded that ALDH2 rs671 G>A polymorphism may decrease the risk of EH. Furthermore, susceptibility to EH reduced in males but not in females. As a variant in ALDH2, rs671 G>A could be an attractive candidate for genetic therapy of EH. In addition, more case-control studies should be conducted to strengthen our conclusion and evaluate the gene-gene and gene-environment interactions between the ALDH2 gene and EH.</p>
収録刊行物
-
- International Heart Journal
-
International Heart Journal 61 (3), 562-570, 2020-05-30
一般社団法人 インターナショナル・ハート・ジャーナル刊行会
